🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to estimate overall survival (OS) for particip...
Status
Completed
Location
Local Institution
Start Date
2019-09-16
Trial ID
NCT05421299
Current data on the impact of donor CHIP on long-term recipient outcome rem...
Status
Recruiting
Location
The University of Hong Kong
Start Date
2021-01-01
Trial ID
NCT04689750
Treatments Being Tested
Ovarian cancer (OC) is one of the most lethal cancers in the world due to l...
Status
Recruiting
Location
Catharina Hospital
Start Date
2025-01-01
Trial ID
NCT06611072
Treatments Being Tested
This study investigates safety and efficacy of traumatic bone defects treat...
Status
Unknown
Location
LIMITED LIABILITY COMPANY "A.A. PARTNERS" (Medical company ilaya®)
Start Date
2015-11-20
Trial ID
NCT03103295
Treatments Being Tested
The purpose of this project is to develop a process to identify highly pers...
Status
Unknown
Location
University of California San Diego
Start Date
2013-01
Trial ID
NCT02667093
The investigators will conduct a phase II clinical trial of sequential chim...
Status
Terminated
Location
Beijing Boren Hospital
Start Date
2020-05-01
Trial ID
NCT04340154
Treatments Being Tested
This is a pilot clinical trial of hematopoietic stem cell transplantation f...
Status
Terminated
Location
Children's Hospital Los Angeles
Start Date
2007-01-02
Trial ID
NCT02127892
350 patients with early leukemias were assigned to receive peripheral blood...
Status
Completed
Location
Dr. Norbert Schmitz
Start Date
1995-01
Trial ID
NCT01020175
Treatments Being Tested
Rationale Myelodysplastic syndromes (MDS) are rare cancers with unmet medic...
Status
Unknown
Location
Service d'hématologie séniors - Hôpital St Louis / Université Paris 7
Start Date
2019-09-30
Trial ID
NCT04174547
This phase I/II trial studies the side effects and the best dose of inotuzu...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2012-10-29
Trial ID
NCT01664910